Literature DB >> 6090699

Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion.

D C Johnson, M Wittels, P G Spear.   

Abstract

Envelope proteins and lipids were extracted from purified herpes simplex virus type 1 virions with octyl glucoside and mixed with phosphatidylcholine for preparation of virosomes by removal of the detergent. Greater than 85% of the extracted envelope proteins, including all the glycoproteins and the nonglycosylated protein designated VP16, were associated with virosomes, which ranged in density from ca. 1.07 to 1.13 g/cm3. All the glycoproteins except gC were as susceptible to degradation by added protease in virosomes as in virions, indicating similar orientations in both. Approximately 30 to 40% of radiolabel incorporated into virosomes bound to HEp-2 cells within 1.5 h at either 4 or 37 degrees C. The cell-bound virosomes were enriched for gB and deficient in other glycoproteins, in comparison with unbound or total virosomes. Binding of virosomes to HEp-2 cells could be inhibited by purified virus, heparin, and monospecific antiviral antibodies. Polyclonal and monoclonal anti-gB antibodies were more effective at inhibiting virosome binding than were anti-gD or anti-gC antibodies. Virosomes depleted of gB or gD did not bind to cells as efficiently as did virosomes containing all the extracted enveloped components; this loss of binding activity was especially pronounced on depletion of gB. The binding of herpes simplex virus type 1 virosomes to cells is discussed in relation to possible heterogeneity of the virosomes and comparisons with binding of virions to cells. We also present electron microscopic evidence that bound virosomes can fuse with the cell surface.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090699      PMCID: PMC254511     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins.

Authors:  R Manservigi; P G Spear; A Buchan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40.

Authors:  Y Hosaka; Y K Shimizu
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

3.  Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.

Authors:  P G Spear; B Roizman
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

4.  Adsorption, penetration and uncoating of herpes simplex virus.

Authors:  E Hochberg; Y Becker
Journal:  J Gen Virol       Date:  1968-03       Impact factor: 3.891

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Comparison of the virion proteins specified by herpes simplex virus types 1 and 2.

Authors:  E N Cassai; M Sarmiento; P G Spear
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

7.  Reconstitution of Semliki forest virus membrane.

Authors:  A Helenius; E Fries; J Kartenbeck
Journal:  J Cell Biol       Date:  1977-12       Impact factor: 10.539

8.  Inhibitory effect of heparin on herpes simplex virus.

Authors:  A J Nahmias; S Kibrick
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

9.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  37 in total

1.  The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines.

Authors:  E L Bearer; P Satpute-Krishnan
Journal:  Curr Drug Targets Infect Disord       Date:  2002-09

2.  Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm.

Authors:  Aaron Farnsworth; Kimberly Goldsmith; David C Johnson
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Bovine herpesvirus type 1 gp87 mediates both attachment of virions to susceptible cells and hemagglutination.

Authors:  K Okazaki; E Honda; T Minetoma; T Kumagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides.

Authors:  D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity.

Authors:  B C Herold; D WuDunn; N Soltys; P G Spear
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains.

Authors:  V Feenstra; M Hodaie; D C Johnson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.

Authors:  R S Haddad; L M Hutt-Fletcher
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Glycoprotein B of bovine herpesvirus type 4: its phylogenetic relationship to gB equivalents of the herpesviruses.

Authors:  M Goltz; H Broll; A Mankertz; W Weigelt; H Ludwig; H J Buhk; K Borchers
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

9.  Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene.

Authors:  M S Parcells; A S Anderson; R W Morgan
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

10.  Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV.

Authors:  X P Liang; L A Babiuk; S van Drunen Littel-van den Hurk; D R Fitzpatrick; T J Zamb
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.